SNDX - Syndax Pharmaceuticals Inc
IEX Last Trade
20.54
0.330 1.607%
Share volume: 576,713
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$20.21
0.33
1.63%
Fundamental analysis
29%
Profitability
38%
Dept financing
4%
Liquidity
75%
Performance
15%
Performance
5 Days
-0.15%
1 Month
-8.30%
3 Months
6.53%
6 Months
-13.94%
1 Year
9.42%
2 Year
-11.50%
Key data
Stock price
$20.54
DAY RANGE
N/A - N/A
52 WEEK RANGE
$11.22 - $25.34
52 WEEK CHANGE
$0.05
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
Company detail
CEO: Briggs Morrison
Region: US
Website: http://www.syndax.com/
Employees: 112
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.syndax.com/
Employees: 112
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
syndax pharmaceuticals is a biotechnology company located at 35 gatehouse dr., building d, floor 3, waltham, ma 02451.
Recent news